AI assistant
Sending…
BIO-TECHNE Corp — Director's Dealing 2006
Jun 21, 2006
30718_dirs_2006-06-21_3aa4b28d-7c0d-456d-ab68-f76d2de98cf5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TECHNE CORP /MN/ (tech)
CIK: 0000842023
Period of Report: 2006-06-19
Reporting Person: VERONNEAU MARCEL (VP - Hematology Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2006-06-19 | Common Stock | M | 1498 | $12.6875 | Acquired | 30444 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2006-06-19 | Employee stock option | $12.6875 | M | 1498 | Disposed | 2006-06-30 | Common stock (1498) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock | 6140 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee stock option | $65 | 2007-06-30 | Common stock (338) | 338 | Direct |
| Employee stock option | $32.5 | 2008-06-30 | Common stock (748) | 748 | Direct |
| Employee stock option | $28.22 | 2009-06-30 | Common stock (785) | 785 | Direct |
| Employee stock option | $33.85 | 2010-08-13 | Common stock (670) | 670 | Direct |
| Employee stock option | $37.011 | 2010-11-30 | Common stock (15000) | 15000 | Direct |
| Employee stock option | $40.47 | 2011-07-08 | Common stock (505) | 505 | Direct |
| Employee stock option | $51.6 | 2012-08-17 | Common stock (475) | 475 | Direct |
Footnotes
F1: Exercisable 5,000 each on 12/1/03; 12/1/04; and 12/1/05
More from BIO-TECHNE Corp
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 19
Board/Management Information
2026
Feb 11
Director's Dealing
2026
Feb 5
Interim / Quarterly Report
2026
Feb 4